Bristol Myers Squibb (CELG-RI) Net Income - Minority (2009 - 2024)

Bristol Myers Squibb (CELG-RI) posted quarterly Net Income - Minority of -$58.0 million for Q3 2024, down 7.41% sequentially from -$54.0 million in Q2 2024.

Bristol Myers Squibb (CELG-RI) Net Income - Minority (2009 - 2024) Analysis & Trends

Bristol Myers Squibb has disclosed Net Income - Minority across 15 years of filings, most recently posting -$58.0 million for Q3 2024.

  • In Q3 2024, Net Income - Minority changed N/A year-over-year to -$58.0 million; the TTM figure through Sep 2024 stood at -$58.0 million (changed N/A YoY), while the FY2023 annual figure was -$55.0 million, changed N/A from the prior year.
  • Net Income - Minority declined to -$58.0 million in Q3 2024, from -$54.0 million in the prior quarter.
  • Over the last five years, Net Income - Minority for CELG-RI reached as high as -$54.0 million in Q2 2024 and fell as low as -$72.0 million in Q3 2020.
  • The 4-year median for Net Income - Minority is -$66.0 million (2020), against an average of -$63.6 million.
  • Annual changes were most pronounced in 2020 — Net Income - Minority soared 40.0% — and 2021, when it slipped 3.03%.
  • A 4-year view of Net Income - Minority shows it stood at -$60.0 million in 2020, then declined by 18.33% to -$71.0 million in 2021, then increased by 22.54% to -$55.0 million in 2023, then declined by 5.45% to -$58.0 million in 2024.
  • According to Business Quant data, Net Income - Minority over the past three periods registered -$58.0 million, -$54.0 million, and -$55.0 million for Q3 2024, Q2 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income - Minority (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Bristol Myers Squibb 244.56 Mn -10.21 Bn 8.07 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2024 -58.00 Mn
Jun 30, 2024 -54.00 Mn
Dec 31, 2023 -55.00 Mn
Sep 30, 2021 -71.00 Mn
Jun 30, 2021 -66.00 Mn
Mar 31, 2021 -68.00 Mn
Dec 31, 2020 -60.00 Mn
Sep 30, 2020 -72.00 Mn
Jun 30, 2020 -66.00 Mn
Mar 31, 2020 -66.00 Mn
Dec 31, 2019 -100.00 Mn
Sep 30, 2019 -106.00 Mn
Jun 30, 2019 -102.00 Mn
Mar 31, 2019 -99.00 Mn
Dec 31, 2018 -96.00 Mn
Sep 30, 2018 -110.00 Mn
Jun 30, 2018 -101.00 Mn
Mar 31, 2018 -113.00 Mn
Dec 31, 2017 -106.00 Mn
Sep 30, 2017 -131.00 Mn